T. Ka´lai et al. / Tetrahedron Letters 43 (2002) 8125–8127
8127
6. Krishna, M. C.; Degraff, W.; Hankovszky, H. O.; Sa´r, P.
C.; Ka´lai, T.; Jeko, J.; Russo, A.; Mitchell, J. B.; Hideg,
K. J. Med. Chem. 1998, 41, 3477.
7. Sosnovsky, G.; Li, S. W.; Rao, N. U. M.; Brasch, R. C.
ical and spectroscopic data for selected compounds: 2a:
mp 179–182°C, calcd for C9H14NO4: C, 53.99; H, 7.05;
N, 7.00; found: C, 53.83; H, 7.01; N, 6.99%. 1H NMR
(CDCl3) (400 MHz) 3.87 (s, 1H), 1.60 (s, 3H), 1.52 (s,
3H), 1.45 (s, 3H), 1.39 (s, 3H). MS (EI) m/z (rel. int.%)
200 (M+, 4), 199 (23), 126 (27), 113 (100). 2b: mp 142–
144°C, calcd for C10H16NO4: C, 56.06; H, 7.53; N, 6.54;
found: C, 56.20; H, 7.41; N, 6.40%. MS (EI) m/z (rel.
int.%) 214 (M+, 5), 200 (2), 116 (4), 41 (100). 2c: mp
153–155°C calcd for C15H18NO4: C, 65.20; H, 6.57; N,
5.07; found: C, 65.32; H, 6.50; N, 4.93%. MS (EI) m/z
(rel. int.%): 276 (M+, 6), 246 (3), 132 (100), 91 (69). 5a:
mp 100–102°C, calcd for C9H16NO3: C, 58.05; H, 8.66;
N, 7.52; found: C, 58.01; H, 8.64; N, 7.48%. MS (EI) m/z
(rel. int.%) 186 (M+, 9), 156 (19), 97 (35), 41 (100). 5b: mp
103–105°C, calcd for C9H15BrNO2: C, 43.39; H, 6.07; N,
5.62; found: C, 43.42; H, 6.11; N, 5.55%. MS (EI) m/z
(rel. int.%) 248/250 (M+, 7/7), 218/220 (11/11), 139 (17),
43 (100). 5c: mp 127–129°C, calcd for C10H18NO4S2: C,
42.84; H, 6.47; N, 5.00; S, 22.87; found: C, 42.90; H, 6.45:
N, 4.94; S, 22.75%. MS (EI) m/z (rel. int.%) 280 (M+, 7),
250 (3), 171 (48), 44 (100). 7: mp 44–46°C, calcd for
C10H16NO2: C, 65.91; H, 8.85; N, 7.69; found: C, 65.95;
H, 8.86; N, 7.72%. MS (EI) m/z (rel. int.%) 182 (M+, 47),
137 (55), 107 (74), 43 (100). 8: mp 78–80 °C, calcd for
C10H16NO3: C, 60.59; H, 8.14; N, 7.07; found: C, 60.60;
3
Z. Naturforsch. 1985, 40b, 1588.
8. Ka´lai, T.; Jeko
9. Adam, W.; Jeko
3
, J.; Hideg, K. Synthesis 2000, 831.
, J.; Le´vai, A.; Majer, Z.; Nemes, Cs.;
3
Patonay, T.; Pa´rka´nyi, L.; Sebok, P. Tetrahedron: Asym-
metry 1996, 7, 2437.
10. Bordeaux, P. D.; Gagnaire, G.; Lajze´rowitcz, J.; Com-
mandeur, G. Acta Crystallogr., Sect. C 1983, 39, 1656.
11. Rozantsev, E. G.; Kagan, E. Sh.; Sholle, V. D. In Bioac-
tive Spin Labels; Rozantsev, E. G., Ed.; Springer-Verlag:
Berlin, 1992; pp. 83–118 and references cited therein.
12. Ozhogina, O. A. Tetrahedron Lett. 2002, 43, 553.
13. Hideg, K.; Hankovszky, H. O.; Lex, L.; Kulcsa´r, Gy.
Synthesis 1980, 911.
14. Hankovszky, H. O.; Hideg, K.; Sa´r, P. C.; Lovas, M. J.;
Jerkovich, Gy. Synthesis 1990, 59.
15. Columbus, L.; Ka´lai, T.; Jeko3 , J.; Hideg, K.; Hubbell, W.
L. Biochemistry 2001, 40, 3828.
16. Berliner, L. J.; Gru¨nwald, J.; Hankovszky, H. O.; Hideg,
K. Anal. Biochem. 1982, 119, 450.
17. Ka´lai, T.; Balog, M.; Jeko, J.; Hideg, K. Synthesis 1999,
973.
18. Tretyakova, N. Y.; Lin, Y.; Upton, P. B.; Sangaiah, R.;
Swenberg, J. A. Toxicology 1996, 113, 70.
19. Hideg, K.; Lex, L. J. Chem. Soc., Perkin 1 1987, 1117.
1
H, 8.20; N, 7.02%. H NMR (CDCl3) (400 MHz) 2.79 (d,
J=4.7 Hz, 2H), 2.58 (d, J=4.7 Hz, 2H), 1.18 (s, 6H),
1.15 (s, 6H). MS (EI) m/z (rel. int.%) 198 (M+, 100), 184
(23), 153 (40), 123 (49). 10: orange oil, calcd for
C9H16NO2: C, 63.50; H, 9.47; N, 8.23; found: C, 63.33;
H, 9.40; N, 8.06%. MS (EI) m/z (rel. int.%) 170 (M+, 3),
128 (6), 113 (9), 43 (100). 11: yellow oil, calcd for
C9H18NO2: C, 62.76; H, 10.53; N, 8.13; found: C, 62.60;
H, 10.41; N, 7.95%. MS (EI) m/z (rel. int.%) 172 (M+, 1),
128 (52), 112 (24), 41 (100).
20. Sa´r, C. P.; Jeko
3 , J.; Fajer, P.; Hideg, K. Synthesis 1999,
1039.
21. Compounds were characterized by ESR, MS, NMR and
elemental analysis. Spectra were in each case consistent
with the assigned structures. All the monoradicals exhib-
ited free equidistant lines aN=14.7–15.5 G. To obtain
high resolution NMR spectra of the NO radicals were
reduced to diamagnetic N-hydroxy compounds by codis-
solving PhNHNHPh reducing agent in NMR tube. Phys-